ABBV

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

AbbVie Inc

NYSE | ABBV

220.81

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 17, 2025)

$382.04B

Market Cap

102.98

P/E Ratio

2.1

EPS

$221.77

52 Week High

$159.41

52 Week Low

HEALTHCARE

Sector

ABBV Chart

Recent Chart
Price Action

ABBV Technicals

Tags:

ABBV Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $39B
Total Revenue $56B
Cost Of Revenue $17B
Costof Goods And Services Sold $17B
Operating Income $9.1B
Selling General And Administrative $11B
Research And Development $13B
Operating Expenses $30B
Investment Income Net -
Net Interest Income -$2.2B
Interest Income $648M
Interest Expense $2.8B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.4B
Income Before Tax $3.7B
Income Tax Expense -$570M
Interest And Debt Expense -
Net Income From Continuing Operations $4.3B
Comprehensive Income Net Of Tax -
Ebit $6.5B
Ebitda $15B
Net Income $4.3B

Revenue & Profitability

Earnings Performance

ABBV Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $135B
Total Current Assets $26B
Cash And Cash Equivalents At Carrying Value $5.5B
Cash And Short Term Investments $5.5B
Inventory $4.2B
Current Net Receivables $11B
Total Non Current Assets $110B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $60B
Intangible Assets Excluding Goodwill $60B
Goodwill $35B
Investments -
Long Term Investments $279M
Short Term Investments $31M
Other Current Assets $4.9B
Other Non Current Assets -
Total Liabilities $132B
Total Current Liabilities $39B
Current Accounts Payable $2.9B
Deferred Revenue -
Current Debt -
Short Term Debt $6.8B
Total Non Current Liabilities $93B
Capital Lease Obligations -
Long Term Debt $60B
Current Long Term Debt $6.8B
Long Term Debt Noncurrent -
Short Long Term Debt Total $68B
Other Current Liabilities $29B
Other Non Current Liabilities $28B
Total Shareholder Equity $3.3B
Treasury Stock -
Retained Earnings -$7.9B
Common Stock $18M
Common Stock Shares Outstanding $1.8B

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $19B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.4B
Capital Expenditures $974M
Change In Receivables -
Change In Inventory -$319M
Profit Loss -
Cashflow From Investment -$21B
Cashflow From Financing -$5.2B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $11B
Dividend Payout Common Stock $11B
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$1.7B
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $4.3B

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $39B
Total Revenue $56B
Cost Of Revenue $17B
Costof Goods And Services Sold $17B
Operating Income $9.1B
Selling General And Administrative $11B
Research And Development $13B
Operating Expenses $30B
Investment Income Net -
Net Interest Income -$2.2B
Interest Income $648M
Interest Expense $2.8B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.4B
Income Before Tax $3.7B
Income Tax Expense -$570M
Interest And Debt Expense -
Net Income From Continuing Operations $4.3B
Comprehensive Income Net Of Tax -
Ebit $6.5B
Ebitda $15B
Net Income $4.3B

Dividends

Field Value
Ex Dividend Date 2025-10-15
Declaration Date 2025-09-05
Record Date 2025-10-15
Payment Date 2025-11-14
Amount 1.64

ABBV News

ABBV Profile

AbbVie Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

AbbVie Inc is a leading American biopharmaceutical company, established in 2013 from a spin-off of Abbott Laboratories. The company specializes in the research, development, and commercialization of advanced therapies in immunology, oncology, virology, and neuroscience. With a robust pipeline of innovative treatments, AbbVie is committed to addressing some of the world's most challenging health issues and is recognized for its blockbuster immunology drug, Humira. AbbVie continues to strengthen its portfolio through strategic acquisitions and collaborations, positioning itself as a formidable player in the global biopharmaceutical landscape.

ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NEHC
-4.00%
$0.45
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RXRX
-2.68%
$4.71
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NEHC
-4.00%
$0.45
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RXRX
-2.68%
$4.71
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.